5.60Open5.60Pre Close0 Volume82 Open Interest12.50Strike Price0.00Turnover368.18%IV4.68%PremiumDec 20, 2024Expiry Date4.79Intrinsic Value100Multiplier5DDays to Expiry0.81Extrinsic Value100Contract SizeAmericanOptions Type0.8347Delta0.0336Gamma3.09Leverage Ratio-0.1917Theta0.0012Rho2.58Eff Leverage0.0050Vega
MediWound Stock Discussion
·3 mins ago
Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns
No comment yet